Xenetic Biosciences Appoints Timothy Cote, MD, MPH, Former Head of FDA Orphan Drug Division, to Board of Directors
February 10, 2014 07:01 ET
|
Xenetic Biosciences, Inc.
LEXINGTON, Mass., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Xenetic Biosciences, Inc. (OTCBB:GAIFD), a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics,...
Xenetic Biosciences Announces Restructured Licensing Agreement With Baxter Now Totaling Up to $100 Million, in Addition to $10 Million Equity Investment
January 30, 2014 07:01 ET
|
Xenetic Biosciences, Inc.
LEXINGTON, Mass., Jan. 30, 2014 (GLOBE NEWSWIRE) -- Xenetic Biosciences, Inc. (OTCBB:GAIFD), a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics,...